Top Markets
#1 Glidr Glidr +51.75%
#2 Akedo Akedo +49.85%
#3 DOVU DOVU +47.86%
#4 Velvet Velvet +43.76%
#5 Black Phoenix Black Phoenix +34.36%
#6 Cross Cross +21.02%
#7 Perle Perle +19.03%
#8 τemplar τemplar +16.86%
#9 Cysic Cysic +15.93%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +15.88%
Coin of the day
Glidr Glidr
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Doseology Sciences Inc. Doseology Sciences Inc.

Doseology Sciences Inc.

MOOD
Classement en actions #38361
Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the... Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada. The company also offers medicinal mushroom products, including tinctures. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distributors. The company was formerly known as Pcybin Therapeutic Inc. and changed its name to Doseology Sciences Inc. in January 2020. Doseology Sciences Inc. was incorporated in 2019 and is based in Kelowna, Canada.
Prix de l'action
$0.12843896
Capitalisation boursière
$1.03M
Changement (1 jour)
0.00%
Changement (1 an)
-80.29%
Pays
CA
Échange Doseology Sciences Inc. (MOOD)

Catégorie

Healthcare
Bénéfices pour Doseology Sciences Inc. (MOOD)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Doseology Sciences Inc., les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Doseology Sciences Inc. de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US